Late last month, Boston Scientific announced it was pausing a study examining pulsed field ablation as a first-line therapy. | Boston Scientific aims to see whether its Farapulse platform can deliver ...
Original Image Link
Source:www.fiercebiotech.com
Original Image Link
Source:www.fiercebiotech.com
Posted: 2024-11-11 05:35:00